(Q54358697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Progress towards personalized medicine for ameloblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

main subject

personalized medicine

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Carolina Cavalieri Gomes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Marina G Diniz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

488-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

Review article: Current concepts of ameloblastoma pathogenesis.

14 March 2020

cites work

1 reference

KRAS and BRAF: drug targets and predictive biomarkers

21 January 2018

1 reference

BRAF(E600) in benign and malignant human tumours

21 January 2018

1 reference

High frequency of BRAF V600E mutations in ameloblastoma

21 January 2018

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

21 January 2018

1 reference

Implications of intratumour heterogeneity for treatment stratification

21 January 2018

1 reference

The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?

21 January 2018

1 reference

Heterogeneity of kinase inhibitor resistance mechanisms in GIST

21 January 2018

1 reference

Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma

21 January 2018

1 reference

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

21 January 2018

1 reference

BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression

21 January 2018

1 reference

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

21 January 2018

1 reference

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

21 January 2018

1 reference

Mouse tumour models to guide drug development and identify resistance mechanisms

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24749150%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference